Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TTEK
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -1.03 1.24 1.25
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -3.92 7.02 7.31
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 2.75 29.63 28.84
Cash 5.51 3.93 3.73
Capex -15.58 -0.07 -0.06
Free Cash Flow 1603.27 1.85 0.11
Revenue 1.58 23.40 23.04
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 6.89 0.17 0.16
Operating Margin 3.97 0.09 0.09
ROA -1.03 0.02 0.02
ROE -1.07 0.05 0.05
ROIC 5.00 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TTEK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TTEK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TTEK is permitted for members.